RenovoRX

Investor Relations

Latest Financial Results

Aug 12, 2026 • 4:05 PM EDT

Q2 2026 Quarterly Results

Quarter Ended Jun 30, 2026

Earnings Release
PDF HTML
Earnings Webcast
Audio

Latest News

View All News
View All News

Latest Presentation

Corporate Overview

View Presentation
View All Presentations

Upcoming Event

Jones Hosts: The Evolving Pancreatic Cancer Landscape: The Role of RenovoRx's TAMP Platform and Emerging Clinical Advances

View Event
Add to Calendar
View All Events

Latest Financial Results

Q2 2026

Quarter Ended June 30, 2026

Latest Annual Filing

For Fiscal Year Ending December 31, 2025

Report Links

Stock Snapshot

IR Contacts

Company

RenovoRX, Inc.
2570 W. El Camino Real
Suite 640
Mountain View, CA 94040
info@renovorx.com

Investor Relations

KCSA Strategic Communications
Valter Pinto or Jack Perkins
T: 212-896-1254
renovorx@kcsa.com

Transfer Agent

Pacific Stock Transfer Company
6725 Via Austi Pkwy
Suite 300
Las Vegas, Nevada 89119
T: 702-361-3033
F: 702-433-1979

Menu

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.